APA (7th ed.) Citation

Wei, B., Michael, H. T., Halsey, C. H., Peer, C. J., Adhikari, A., Dwyer, J. E., . . . Simpson, R. M. (2016). Synergistic targeted inhibition of MEK and dual PI3K/ mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma. Pigment Cell & Melanoma Research, 29(6), 643. https://doi.org/10.1111/pcmr.12512

Chicago Style (17th ed.) Citation

Wei, Bih‐Rong, et al. "Synergistic Targeted Inhibition of MEK and Dual PI3K/ MTOR Diminishes Viability and Inhibits Tumor Growth of Canine Melanoma Underscoring Its Utility as a Preclinical Model for Human Mucosal Melanoma." Pigment Cell & Melanoma Research 29, no. 6 (2016): 643. https://doi.org/10.1111/pcmr.12512.

MLA (9th ed.) Citation

Wei, Bih‐Rong, et al. "Synergistic Targeted Inhibition of MEK and Dual PI3K/ MTOR Diminishes Viability and Inhibits Tumor Growth of Canine Melanoma Underscoring Its Utility as a Preclinical Model for Human Mucosal Melanoma." Pigment Cell & Melanoma Research, vol. 29, no. 6, 2016, p. 643, https://doi.org/10.1111/pcmr.12512.